Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, North Carolina, United States of America.
PLoS One. 2012;7(6):e39414. doi: 10.1371/journal.pone.0039414. Epub 2012 Jun 27.
BACKGROUND: Mortality and morbidity from HIV have dramatically decreased in both high- and low-income countries. However, some patients may not benefit from combination antiretroviral therapy (cART) because of inadequate access to HIV care, including attrition after care initiation. METHODOLOGY/PRINCIPAL FINDINGS: The study population included all HIV-infected patients receiving cART through the Chinese National Free Antiretroviral Treatment Program from 1 January 2003 to 31 December 2010 (n = 106,542). We evaluated retention in HIV care and used multivariable Cox proportional hazard models to identify independent factors predictive of attrition. The cumulative probability of attrition from cART initiation was 9% at 12 months, 13% at 18 months, 16% at 24 months and 24% at 60 months. A number of factors were associated with attrition, including younger age, male gender, and being single or divorced. Patients with higher CD4 cell counts at cART initiation were more likely to drop out of HIV care. The proportion of patients remaining in HIV care increased in more recent calendar years and among patients who initiated modern cART regimens. CONCLUSIONS/SIGNIFICANCE: Retention in HIV care is essential for optimizing individual and public health outcomes. Attrition, even the degree observed in our study, can lead to premature morbidity and mortality, and possibly affect further transmission of HIV and HIV resistant drug variants. Effective strategies to promote retention in HIV care programs are needed. In China these strategies may include focusing particularly on younger male patients and those with higher CD4 cell counts at therapy initiation.
背景:在高收入和低收入国家,艾滋病毒的死亡率和发病率都显著下降。然而,由于获得艾滋病毒护理的机会有限,包括护理开始后的损耗,一些患者可能无法从联合抗逆转录病毒疗法(cART)中获益。
方法/主要发现:研究人群包括所有 2003 年 1 月 1 日至 2010 年 12 月 31 日通过中国国家免费抗逆转录病毒治疗计划接受 cART 的艾滋病毒感染者(n = 106542)。我们评估了艾滋病毒护理的保留情况,并使用多变量 Cox 比例风险模型确定了与损耗相关的独立因素。从 cART 开始的损耗累积概率为 12 个月时为 9%,18 个月时为 13%,24 个月时为 16%,60 个月时为 24%。许多因素与损耗有关,包括年龄较小、男性、单身或离异。在 cART 开始时 CD4 细胞计数较高的患者更有可能退出艾滋病毒护理。在最近的历年中,留在艾滋病毒护理中的患者比例有所增加,并且在开始现代 cART 方案的患者中也是如此。
结论/意义:保留在艾滋病毒护理中对于优化个人和公共卫生结果至关重要。损耗,即使是我们研究中观察到的程度,也会导致过早发病和死亡,并可能影响艾滋病毒和耐药药物变体的进一步传播。需要采取有效的策略来促进艾滋病毒护理方案中的保留。在中国,这些策略可能包括特别关注年轻男性患者和那些在治疗开始时 CD4 细胞计数较高的患者。
Lancet Reg Health Southeast Asia. 2025-2-24
BMC Infect Dis. 2019-12-10
N Engl J Med. 2011-7-18
Trop Med Int Health. 2010-6
J Acquir Immune Defic Syndr. 2010-2